PROCEPT BioRobotics Corporation Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received
PROCEPT BioRobotics Corporation (PRCT) had Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received of $5.90 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases › Sales-Type and Direct Financing Leases, Payment to be Received, Fiscal Year Maturity
us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived · last filed 2026-08-05
- 2026-06-30: Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received $5.90M.
- 2026-03-31: Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received $5.48M.
- 2025-12-31: Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received $5.83M.
- 2025-09-30: Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received $5.02M.
| Period end | Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received |
|---|---|
| 2026-06-30 | $5.90M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $5.48M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $5.83M 10-K · filed 2026-02-26 |
| 2025-09-30 | $5.02M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $3.94M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $2.49M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $2.10M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |